九福来

New Anti-Aids medicine (PMAS) was approved by Tanzania Medicine and Medical Devices Authority

New Anti-Aids medicine (PMAS) was approved by Tanzania Medicine and Medical Devices Authority

Congratulations to the national high-tech enterprise Kaifeng Jufeel Biotechnology Co., Ltd. On July 14, 2020, the hit product of the company, PMAS aloe vera gel was officially approved by the Tanzania Tanzania Medicine and Medical Devices Authority (TMDA) as an over-the-counter drug for the treatment of AIDS. The trade name of the medicine is: Jufeel PMAS aloe vera gel 8000mg/l, and the drug registration number is: Tan 20 HB 0084.

 

It is reported that PMAS is different from the cocktail therapy which involves a large number of other antiviral drugs. PMAS is a single biological preparation mainly composed of Acemannan extracted from Aloe Vera.

 

According to the clinical trials report on AIDS treatment in Tanzania 10 public hospitals, it is fast in efficacy and the effect is remarkable. What is more, there is no obvious side effect. Within three months, the average HIV load in the blood of patients who participated the clinical trials decreased by 73.6%, and the HIV viral load in blood of many patients dropped to 0. Anti AIDS single prescription biological agents represented by PMAS are expected to become an safer and more efficient AIDS control programs. From the reliable source in Tanzanian hospitals said that the PMAS reflected the future development trend of AIDS treatment program.

 

Back to list